{"url_path":"/sec/tela/8-k/2026-06-11/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 **","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-11","source_url":"https://www.sec.gov/Archives/edgar/data/1561921/0001104659-26-072931-index.html","accession_number":"0001104659-26-072931","cik":"0001561921","ticker":"TELA","issuer_name":"TELA Bio, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1561921/0001104659-26-072931-index.html","primary_entity_key":"0001561921","primary_entity_name":"TELA Bio, Inc."},"word_count":106,"has_tables":true,"body_markdown":"**Item 9.01**\n**Financial Statements and Exhibits.**\n\n \n\n**(d) Exhibits**\n\n \n\nThe following exhibits are being filed herewith:\n\n \n\n**Exhibit No.**\n \n**Document**\n\n[10.1#](tm2617369d1_ex10-1.htm)\n \n[Amendment No. 2 to TELA Bio, Inc. Amended & Restated 2019 Equity Incentive Plan.](tm2617369d1_ex10-1.htm)\n\n104\n \nCover Page Interactive Data File (embedded within the Inline XBRL document).\n\n \n\n# Indicates a management contract any compensatory plan, contract or\narrangement.\n\n \n\n \n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant to the requirements of the Securities\nExchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\nTELA BIO, INC.\n \n\n \n \n\nBy:\n/s/\nAntony Koblish\n \n\n*Name:*\n*Antony Koblish*\n \n\n*Title:*\n*Chief Executive Officer\nand Director*\n \n\n \n\nDate: June 11, 2026"}